Ghattas Mohammad A, Mansour Ramez A, Atatreh Noor, Bryce Richard A
College of Pharmacy, Al Ain University of Science and Technology, Al Ain, 64141, United Arab Emirates.
Manchester Pharmacy School, University of Manchester, Manchester, M13 9PT, UK.
Chem Biol Drug Des. 2016 Jan;87(1):131-42. doi: 10.1111/cbdd.12635. Epub 2015 Sep 16.
Enoyl-acyl carrier protein reductases have an important role in fatty acid biosynthesis and are considered essential for bacterial and protozoal survival. Here, we perform a computational assessment of enoyl-acyl carrier protein reductase structures, providing insights for inhibitor design that we incorporate into a virtual screening approach. Firstly, we analyse 80 crystal structures of 16 different enoyl-acyl carrier protein reductases for their active site characteristics and druggability, finding these sites contain a readily druggable pocket, of varying size and shape. Interestingly, a high affinity, potentially allosteric site was identified for pfFabl. Analysis of the ligand-protein interactions of four enoyl-acyl carrier protein reductases from different micro-organisms (InhA, pfFabl, saFabl and ecFabl), involving 59 available crystal structures, found three commonly shared interactions; constraining these interactions in docking improved enrichment of enoyl-acyl carrier protein reductase virtual screens, by up to 60% in the top 3% of the ranked library. This docking protocol also improved pose prediction, decreasing the root-mean-square deviation to crystallographic pose by up to 75% on average. The binding site analysis and knowledge-based docking protocol presented here can potentially assist in the structure-based design of new enoyl-acyl carrier protein reductase inhibitors.
烯酰 - 酰基载体蛋白还原酶在脂肪酸生物合成中具有重要作用,被认为是细菌和原生动物生存所必需的。在此,我们对烯酰 - 酰基载体蛋白还原酶结构进行了计算评估,为抑制剂设计提供了见解,并将其纳入虚拟筛选方法中。首先,我们分析了16种不同烯酰 - 酰基载体蛋白还原酶的80个晶体结构,以了解其活性位点特征和可成药性,发现这些位点包含一个易于成药的口袋,大小和形状各异。有趣的是,还为疟原虫烯酰 - 酰基载体蛋白还原酶(pfFabl)确定了一个高亲和力的潜在变构位点。对来自不同微生物的四种烯酰 - 酰基载体蛋白还原酶(结核分枝杆菌烯酰 - 酰基载体蛋白还原酶(InhA)、疟原虫烯酰 - 酰基载体蛋白还原酶(pfFabl)、金黄色葡萄球菌烯酰 - 酰基载体蛋白还原酶(saFabl)和大肠杆菌烯酰 - 酰基载体蛋白还原酶(ecFabl))的配体 - 蛋白质相互作用进行分析,涉及59个可用晶体结构,发现了三种共同的相互作用;在对接中限制这些相互作用可提高烯酰 - 酰基载体蛋白还原酶虚拟筛选的富集度,在排名库的前3%中提高多达60%。这种对接方案还改善了构象预测,平均将与晶体学构象的均方根偏差降低了多达75%。本文介绍的结合位点分析和基于知识的对接方案可能有助于基于结构的新型烯酰 - 酰基载体蛋白还原酶抑制剂设计。